Treatments for localized prostate cancer: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation.
Chou R, Dana T, Bougatsos C, Fu R, Blazina I, Gleitsmann K, Rugge JB
Record ID 32013000764
English
Authors' objectives:
To systematically review benefits and harms associated with treatments for screen-detected or localized prostate cancer.
Authors' recommendations:
Additional research is needed to understand benefits of treatments for screen-detected, localized prostate cancer. Commonly selected therapies for localized prostate cancer are associated with an increased risk of important harms. More research is needed to understand whether newer therapies and techniques for treating localized prostate cancer are associated with fewer harms.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.ncbi.nlm.nih.gov/books/NBK82315/pdf/TOC.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Prostatic Neoplasms
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.